Antibiotic monitoring during lung transplant recovery
Part of Infections, Lungs & breathing clinical trials.
This study tracks antibiotic levels in your blood after a lung transplant to make sure the dose is right for you. It aims to improve how antibiotics are given to prevent infections during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a lung transplant.
- You are over 18 years old.
- You have not had a lung transplant before.
- You have not had a respiratory infection or bacteria in your lungs in the past year.
- You are not currently taking antibiotics before your transplant.
- You do not have a severe air leak from your lungs after the transplant that requires high breathing support.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This study looks at ways to improve outcomes for people who are waiting for or have recently received a lung transplant. It aims to find better management strategies for both donors and recipients.
This study uses a special test called FilmArray Pneumonia Plus to quickly find germs in your lungs before your lung transplant. The doctors will use the results to adjust your preventive antibiotics, aiming to reduce the risk of pneumonia after the transplant.
This study looks back at the health records of people who had a lung transplant to find out which factors before and during the surgery affect their recovery and long-term outcomes. If you had a lung transplant, your information could help doctors improve care for future patients.
This study looks at how well patients are informed about the risk of infections after a lung or heart-lung transplant. It aims to improve the information given to future patients.
This study compares a lower dose versus the standard dose of the antibiotic TMP-SMX (Bactrim) to prevent a type of lung infection (Pneumocystis pneumonia) after a kidney transplant. If you are eligible, you will receive either a lower or standard dose to see which works just as well with fewer side effects.
Hear when a new Pneumonia, Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.